[go: up one dir, main page]

BRPI0406913A - Dispersão de cristais de sabor mascarado ou de grânulos de substâncias ativas, cápsulas macias mascáveis preenchidas com a referida dispersão, e processo para a preparação da mesma - Google Patents

Dispersão de cristais de sabor mascarado ou de grânulos de substâncias ativas, cápsulas macias mascáveis preenchidas com a referida dispersão, e processo para a preparação da mesma

Info

Publication number
BRPI0406913A
BRPI0406913A BR0406913-7A BRPI0406913A BRPI0406913A BR PI0406913 A BRPI0406913 A BR PI0406913A BR PI0406913 A BRPI0406913 A BR PI0406913A BR PI0406913 A BRPI0406913 A BR PI0406913A
Authority
BR
Brazil
Prior art keywords
dispersion
granules
preparing
capsules filled
crystals
Prior art date
Application number
BR0406913-7A
Other languages
English (en)
Inventor
Julien Meissonnier
Fabrice Rose
Marie Madeleine Bohn
Original Assignee
Scherer Technologies Inc R P
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scherer Technologies Inc R P filed Critical Scherer Technologies Inc R P
Publication of BRPI0406913A publication Critical patent/BRPI0406913A/pt
Publication of BRPI0406913B1 publication Critical patent/BRPI0406913B1/pt
Publication of BRPI0406913B8 publication Critical patent/BRPI0406913B8/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816—Wall or shell material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Zoology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)

Abstract

"DISPERSãO DE CRISTAIS DE SABOR MASCARADO OU DE GRâNULOS DE SUBSTâNCIAS ATIVAS, CáPSULAS MACIAS MASCáVEIS PREENCHIDAS COM A REFERIDA DISPERSãO, E PROCESSO PARA A PREPARAçãO DA MESMA". A presente invenção se refere a uma dispersão de cristais ou de grânulos de substância ativa em um veículo lipófilo, os referidos cristais e grânulos sendo revestidos por um revestimento com o objetivo de mascaramento de sabor. A presente invenção também se refere a formas de dosagem unitárias e de forma preferida a cápsulas de gelatina macia mascáveis ou de rápida dissolução, preenchidas com a referida dispersão assim como a processo para a fabricação da mesma.
BRPI0406913A 2003-01-24 2004-01-21 dispersão de cristais de sabor mascarado ou de grânulos de substâncias ativas, cápsulas macias mascáveis preenchidas com a referida dispersão, e processo para a preparação da mesma BRPI0406913B8 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0300824A FR2850275B1 (fr) 2003-01-24 2003-01-24 Capsules molles a macher contenant une substance active a gout masque
PCT/US2004/001463 WO2004066925A2 (en) 2003-01-24 2004-01-21 Dispersion of taste masked crystals or granules of active substances, chewable soft capsules filled with said dispersion, and process for preparing same

Publications (3)

Publication Number Publication Date
BRPI0406913A true BRPI0406913A (pt) 2006-01-03
BRPI0406913B1 BRPI0406913B1 (pt) 2016-03-01
BRPI0406913B8 BRPI0406913B8 (pt) 2021-05-25

Family

ID=32669215

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0406913A BRPI0406913B8 (pt) 2003-01-24 2004-01-21 dispersão de cristais de sabor mascarado ou de grânulos de substâncias ativas, cápsulas macias mascáveis preenchidas com a referida dispersão, e processo para a preparação da mesma

Country Status (18)

Country Link
EP (1) EP1592402B1 (pt)
JP (1) JP5371187B2 (pt)
CN (2) CN1741787A (pt)
AR (1) AR042902A1 (pt)
AU (1) AU2004207498B2 (pt)
BR (1) BRPI0406913B8 (pt)
CA (1) CA2512988C (pt)
DK (1) DK1592402T3 (pt)
ES (1) ES2415660T3 (pt)
FR (1) FR2850275B1 (pt)
MX (1) MXPA05007683A (pt)
NO (1) NO339528B1 (pt)
NZ (1) NZ541753A (pt)
PT (1) PT1592402E (pt)
RU (1) RU2362546C2 (pt)
SI (1) SI1592402T1 (pt)
UA (1) UA84140C2 (pt)
WO (1) WO2004066925A2 (pt)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1656117A1 (en) * 2003-08-11 2006-05-17 Merck Frosst Canada Ltd. Flavored taste-masked pharmaceutical formulation made using a one-step coating process
US7169385B2 (en) 2003-09-29 2007-01-30 Ronald G. Udell Solubilized CoQ-10 and carnitine
US8124072B2 (en) 2003-09-29 2012-02-28 Soft Gel Technologies, Inc. Solubilized CoQ-10
WO2005032278A1 (en) 2003-09-29 2005-04-14 Soft Gel Technologies, Inc. SOLUBILIZED CoQ-10
US20070292501A1 (en) * 2006-06-05 2007-12-20 Udell Ronald G Chewable soft gelatin capsules
US20080020022A1 (en) * 2006-06-05 2008-01-24 Udell Ronald G Chewable co-enzyme q-10 capsule
US8343541B2 (en) 2007-03-15 2013-01-01 Soft Gel Technologies, Inc. Ubiquinol and alpha lipoic acid compositions
AU2008276840B2 (en) * 2007-07-19 2013-10-03 R-Tech Ueno, Ltd. Pharmaceutical composition comprising 11-deoxy-prostaglandin compound and method for stabilizing the compound
FR2935084B1 (fr) * 2008-08-19 2011-05-06 Pancosma Sa Pour L Ind Des Produits Biochimiques Additif pour l'alimentation animale et son procede de preparation
GB201006218D0 (en) * 2010-04-14 2010-06-02 Ayanda As Composition
CA2706270C (en) * 2010-06-03 2020-01-07 Accucaps Industries Limited Pharmaceutical formulations of statins and omega-3 fatty acids for encapsulation
CA3065589C (en) 2010-06-03 2022-04-26 Catalent Ontario Limited Multi phase soft gel capsules, apparatus and method thereof
SG192284A1 (en) * 2011-02-11 2013-09-30 Ctc Bio Inc Sildenafil-free base-containing film preparation and method for producing same
EP2696846B1 (en) * 2011-04-11 2018-01-17 Vitux Group AS Oral pharmaceutical dispersion compositions
WO2012144943A1 (en) * 2011-04-18 2012-10-26 Lipidor Ab Liquid carrier for oral delivery of a pharmacologically active agent
CN102241782B (zh) * 2011-05-18 2013-01-30 清华大学 一种淀粉乙酸酯的制备方法及其在去除水中硝酸盐的应用
CN102813275B (zh) 2011-06-10 2015-09-30 杭州养生堂保健品有限公司 一种咀嚼型软胶囊皮和咀嚼型软胶囊
DE102012014848A1 (de) * 2012-07-27 2012-10-31 Heilerde-Gesellschaft Luvos Just GmbH & Co. KG Heilerde-Zubereitung
US20150209360A1 (en) * 2014-01-30 2015-07-30 Orbz, Llc Oral caffeine delivery composition
FR3027802B1 (fr) * 2014-10-31 2018-03-02 Ethypharm Granules de principe actif a double masquage de gout, leur procede de preparation et comprimes orodispersibles les contenant
US9867779B2 (en) 2015-03-26 2018-01-16 Patheon Softgels Inc. Liquisoft capsules
ES2922749T3 (es) * 2016-03-15 2022-09-20 Acer Therapeutics Inc Composiciones de sabor agradable que incluyen fenilbutirato de sodio y sus usos
JP6942342B2 (ja) * 2016-11-02 2021-09-29 富士カプセル株式会社 ソフトカプセル皮膜
JP2018121699A (ja) * 2017-01-30 2018-08-09 株式会社アクレス クリルオイルを充填したカプセル剤
CN107373744B (zh) * 2017-07-13 2018-11-09 云南中烟工业有限责任公司 一种维生素c微胶囊的制备方法及其在卷烟中的应用
CN108524464A (zh) * 2018-05-17 2018-09-14 安士制药（中山）有限公司 一种西甲硅油软胶囊的制备方法
JP7681511B2 (ja) 2019-02-22 2025-05-22 キャタレント・ユーケー・スウィンドン・ザイディス・リミテッド インライン混合中の懸濁液の通気の最小化
GB2597578B (en) 2019-02-22 2023-04-26 Catalent Uk Swindon Zydis Ltd Preserving functionally-coated API particles produced by solventless mixing processes in aqueous suspension
BR112021016421A2 (pt) 2019-02-22 2021-10-13 Catalent U.K. Swindon Zydis Limited Minimização de aglomeração, aeração e preservação do revestimento de composições farmacêuticas que compreendem ibuprofeno
BR112021016485A2 (pt) * 2019-02-22 2021-10-13 Catalent U.K. Swindon Zydis Limited Minimização de aglomeração de material de revestimento de partícula de fármaco durante armazenamento para estabilizar tempos de desintegração de produtos farmacêuticos
AR123109A1 (es) 2020-07-31 2022-10-26 Catalent Uk Swindon Zydis Ltd Composiciones farmacéuticas que comprenden ifa
JP2023549381A (ja) 2020-11-18 2023-11-24 バイオファーマ・シナジーズ，エス．エル． 抗ヒスタミン活性化合物を含む口内分散性粉末組成物

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8623557D0 (en) 1986-10-01 1986-11-05 Boots Co Plc Therapeutic agents
US4851226A (en) * 1987-11-16 1989-07-25 Mcneil Consumer Products Company Chewable medicament tablet containing means for taste masking
GB8813682D0 (en) * 1988-06-09 1988-07-13 Reckitt & Colmann Prod Ltd Pharmaceutical compositions
CH677606A5 (pt) 1988-07-12 1991-06-14 Aesculapius Pharma Sa
US4975465A (en) 1989-03-28 1990-12-04 American Home Products Corporation Orally administrable ibuprofen compositions
CA2063141C (en) 1989-08-04 1997-03-04 Edward J. Roche Rotogranulations and taste masking coatings for preparation of chewable pharmaceutical tablets
US5262179A (en) 1989-09-13 1993-11-16 Nicholas Kiwi Pty Ltd. Non-effervescent ibuprofen compositions
JPH05506011A (ja) 1990-04-11 1993-09-02 ジ・アップジョン・カンパニー 流動床コーティングによるイブプロフェンの味覚マスキング
JP3157233B2 (ja) * 1991-11-22 2001-04-16 エーザイ株式会社 水溶性薬物を含有した軟カプセル剤
JP3136310B2 (ja) * 1992-02-26 2001-02-19 東洋カプセル株式会社 咀嚼服用に適した担体
IT1256022B (it) * 1992-06-08 1995-11-20 Preparazioni farmaceutiche stabili di nicorandil
EP0664701B1 (en) * 1992-10-16 1997-09-10 Glaxo Group Limited Taste-masking compositions of ranitidine
GB9313329D0 (en) * 1993-06-28 1993-08-11 Scherer Ltd R P Softgel capsule shell compositions
US5466865A (en) 1993-07-02 1995-11-14 Ibah, Inc. Neomorphic ibuprofen and methods of using same
DE4322826A1 (de) * 1993-07-08 1995-01-12 Galenik Labor Freiburg Gmbh Pharmazeutisches Präparat
ZA945944B (en) 1993-08-13 1996-02-08 Eurand America Inc Procedure for encapsulating nsaids
US5569466A (en) * 1995-05-17 1996-10-29 R. P. Scherer Corporation Fill compositions for soft elastic gel capsules
US6024980A (en) * 1996-06-28 2000-02-15 Mcneil-Ppc, Inc. Multiphase soft gelatin dosage form
FR2785539B1 (fr) * 1998-11-06 2004-04-09 Prographarm Laboratoires Particules enrobees d'ibuprofene cristallin granule
WO2000051570A1 (fr) * 1999-02-26 2000-09-08 Shionogi & Co., Ltd. Capsules molles a croquer presentant des proprietes d'administration ameliorees et leur procede de production
FR2795962B1 (fr) 1999-07-08 2003-05-09 Prographarm Laboratoires Procede de fabrication de granules enrobes a gout masque et liberation immediate du principe actif
US20030096791A1 (en) * 2001-05-31 2003-05-22 Cima Labs Inc. Taste masking of highly water-soluble drugs

Also Published As

Publication number Publication date
SI1592402T1 (sl) 2013-08-30
CN1741787A (zh) 2006-03-01
EP1592402A2 (en) 2005-11-09
PT1592402E (pt) 2013-06-25
HK1082659A1 (en) 2006-06-16
NO20053681L (no) 2005-08-23
MXPA05007683A (es) 2005-09-30
CA2512988A1 (en) 2004-08-12
CN103169655A (zh) 2013-06-26
DK1592402T3 (da) 2013-06-24
EP1592402B1 (en) 2013-03-20
RU2005126729A (ru) 2006-03-10
FR2850275B1 (fr) 2005-04-08
JP5371187B2 (ja) 2013-12-18
BRPI0406913B8 (pt) 2021-05-25
WO2004066925A3 (en) 2004-10-28
AU2004207498A1 (en) 2004-08-12
NO339528B1 (no) 2016-12-27
AR042902A1 (es) 2005-07-06
WO2004066925A2 (en) 2004-08-12
NZ541753A (en) 2008-12-24
CA2512988C (en) 2015-11-10
UA84140C2 (ru) 2008-09-25
WO2004066925B1 (en) 2004-12-09
FR2850275A1 (fr) 2004-07-30
JP2007525413A (ja) 2007-09-06
EP1592402A4 (en) 2009-01-14
ES2415660T3 (es) 2013-07-26
BRPI0406913B1 (pt) 2016-03-01
AU2004207498B2 (en) 2008-10-30
RU2362546C2 (ru) 2009-07-27

Similar Documents

Publication Publication Date Title
BRPI0406913A (pt) Dispersão de cristais de sabor mascarado ou de grânulos de substâncias ativas, cápsulas macias mascáveis preenchidas com a referida dispersão, e processo para a preparação da mesma
ECSP055918A (es) Procedimiento para modificar la formación de cristal de fármaco
BRPI0507755A (pt) composto de pirazolina substituìda, processo para a sua manufatura, medicamentos e seus usos
BRPI0318811B8 (pt) derivados de ciclohexanol espirocíclicos
BRPI0512242A (pt) derivados de sulfamato e sulfamida úteis para o tratamento de epilepsia e distúrbios relacionados
CY2014042I2 (el) Γλυκοπυρανοζυλο-υποκατεστημενα παραγωγα βενζολιου, φαρμακα που περιεχουν τις ενωσεις αυτες, χρηση αυτων και μεθοδος για την παραγωγη τους
BRPI0512237A (pt) cis-imidazolinas
UY29199A1 (es) Derivados tiazol, composiciones que los contienen, procedimientos de preparación y aplicaciones
BRPI0817262A2 (pt) Compostos derivados de biaril sulfonamida, composições farmacêuticas que os contêm, processo para sua fabricação, método e usos para o tratamento terapêutico e/ou profilático de doenças e usos na preparação de medicamentos
EA200501586A1 (ru) Фармацевтические продукты
BRPI0512974A (pt) novos derivados de hidantoìna para o tratamento de doenças obstrutivas das vias aéreas
ATE482693T1 (de) Pharmazeutische zusammensetzung mit einem omega- carboxyaryl-substituierten diphenylharnstoff zur behandlung von krebs
BRPI0512335A (pt) compostos, processo para a sua manufatura, composições farmacêuticas que os compreendem, método para o tratamento e/ou prevenção de enfermidades e sua utilização
BR0208887A (pt) Derivados de dihidro-benzo[b][1,4]diazepin-2-ona como antagonistas i de mglur2
BRPI0515485A (pt) compostos heteroarila como betamiméticos para o tratamento de doenças das vias respiratórias
BRPI0510411A (pt) derivados de dióxido de oxazol-benzoisotiazol, processos para a sua fabricação e seu uso
BRPI0820203A2 (pt) Compostos de pirrdina, processo para a sua preparação, composição farmacêutica que os compreende, uso de composto e método para o tratamento e/ou profilaxia de diabetes mellitus do tipo ii e outras enfermidades
PE20110019A1 (es) Composicion farmaceutica que contiene un sensibilizante de insulina y un secretagogo de insulina
CO6220856A2 (es) Formas cristalinas de un compuesto de 8-azabiciclo[3,2,1]octano
BRPI0612109A2 (pt) composto, métodos de tratamento ou prevenção de uma doença, formulação farmacêutica, e, processo para preparar um composto
BRPI0818813A2 (pt) Compostos derivados de metil-benzimidazol, processo para a manufatura desses compostos, composições farmacêuticas que os compreendem, método para o tratamento terapêutico e/ ou profilático de enfermidades que são afetadas por moduladores de fxr e uso de tais compostos
BRPI0812432B8 (pt) extrusados, seu uso, e medicamento
BRPI0512986A (pt) novos derivados de hidantoìna
BRPI0615195A8 (pt) preparação farmacêutica, embalagem, e, métodos para tratar doença gastrintestinal, para fabricar uma cápsula e para testar dissolução de cápsulas de balsalazida.
BRPI0519854A2 (pt) 4- feniltetraidroquinolinas substituìdas, métodos para produzì-las, seu uso como fármaco, e fármaco contendo-as

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B15K Others concerning applications: alteration of classification

Free format text: PARA:INT.CI.A61K 47/06, A61K 9/00, A61K 9/48, A61K 9/64, A61P 29/00

Ipc: A61K 47/06 (2011.01), A61K 9/00 (2011.01), A61K 9/

B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 01/03/2016, OBSERVADAS AS CONDICOES LEGAIS.

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 21/01/2004 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF

B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE A 21A ANUIDADE.

B21H Decision of lapse of a patent or of a certificate of addition of invention cancelled [chapter 21.8 patent gazette]

Free format text: ANULADA A PUBLICACAO CODIGO 21.6 NA RPI NO 2810 DE 12/11/2024 POR TER SIDO INDEVIDA.